Basilea Pharmaceutica is a pharmaceutical company based in Basel, Switzerland, that focuses on medicines for serious infections and cancer. It develops and commercialises antibiotics and antifungal treatments used in hospitals, including products for difficult-to-treat bacterial and fungal infections, and it also works on cancer therapies. Its customers are mainly hospitals and healthcare providers, and it works with partners to make its medicines available in markets around the world.
Basilea Pharmaceutica AG trades under the code 0QNA on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #108 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
90/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average22.0%
From 52-week high-1.5%
MomentumStrong
88/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return32.6%
6-month return27.8%
12-month, skipping last month41.9%
Stability (higher is calmer)Strong
72/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)29.0%
Worst drawdown, 1 year (smaller is calmer)-17.5%
LiquidityFair
52/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.89M GBP
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 44.70 – 70.40Daily closes, split-adjusted
Signals
50-day average65.87
200-day average56.44
Golden/death cross (60d)Golden, 44 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.55
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
67.18
Bullish
EMA 10
67.61
Bullish
SMA 20
66.99
Bullish
EMA 20
67.09
Bullish
SMA 50
65.87
Bullish
EMA 50
64.71
Bullish
SMA 100
58.85
Bullish
EMA 100
61.21
Bullish
SMA 200
56.44
Bullish
EMA 200
57.50
Bullish
Oscillators (daily)
RSI (14)
58.39
Neutral
MACD (12, 26)
0.75
Bullish
Momentum (12)
4.64
Bullish
Stochastic %K (14)
85.29
Bearish
Williams %R (14)
-14.71
Bearish
CCI (20)
117.6
Bearish
Pivot points (classic, last session)
S3
66.93
S2
67.62
S1
68.23
Pivot
68.92
R1
69.53
R2
70.22
R3
70.83
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
